Induction of Alzheimer's-like changes in brain of mice expressing mutant APP fed excess methionine

Journal of Neurochemistry

Volumn 116, Issue 1, 2011, Pages 82-92

  McCampbell, Alexander ^a   Wessner, Keith ^a   Marlatt, Michael W ^a   Wolffe, Carrie ^a   Toolan, Dawn ^a   Podtelezhnikov, Alexei ^a   Yeh, Suzie ^a   Zhang, Rena ^a   Szczerba, Peter ^a   Tanis, Keith Q ^a   Majercak, John ^a   Ray, William J ^a   Savage, Mary ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

aging; Alzheimer's; amyloid; cholesterol; homocysteine; methionine

Indexed keywords

ABC TRANSPORTER A1; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CHOLESTEROL; FOLIC ACID; HOMOCYSTEINE; METHIONINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; TAU PROTEIN; VITAMIN B GROUP;

ALZHEIMER DISEASE; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENOTYPE; HYPERHOMOCYSTEINEMIA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; STRAIN DIFFERENCE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MALE; METHIONINE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; VITAMIN B DEFICIENCY;

MUS;

EID: 78650168134     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07087.x     Document Type: Article

References (49)

1. Aisen P. S., Schneider L. S., Sano M., Diaz-Arrastia R., Van Dyck C. H., Weiner M. F., Bottiglieri T., Jin S., Stokes K. T., Thomas R. G., and, Thal L. J., (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. J.A.M.A 300, 1774-1783.
2. Bernardo A., McCord M., Troen A. M., Allison J. D., and, McDonald M. P., (2007) Impaired spatial memory in APP-overexpressing mice on a homocysteinemia-inducing diet. Neurobiol. Aging 28, 1195-1205.
3. Chan A. Y., Alsaraby A., and, Shea T. B., (2008) Folate deprivation increases tau phosphorylation by homocysteine-induced calcium influx and by inhibition of phosphatase activity: alleviation by S-adenosyl methionine. Brain Res. 1199, 133-137.
4. Clarke R., Smith A. D., Jobst K. A., Refsum H., Sutton L., and, Ueland P. M., (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch. Neurol. 55, 1449-1455.
5. Dietschy J. M., and, Turley S. D., (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397.
6. Durga J., Van Boxtel M. P., Schouten E. G., Kok F. J., Jolles J., Katan M. B., and, Verhoef P., (2007) Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 369, 208-216.
7. Eisenga B. H., Collins T. D., and, McMartin K. E., (1992) Incorporation of 3H-label from folic acid is tissue-dependent in folate-deficient rats. J. Nutr. 122, 977-985.
8. Fehling C., Jagerstad M., Lindstrand K., and, Elmquist D., (1976) Reduction of folate levels in the rat: difference in depletion between the central and the peripheral nervous system. Z. Ernahrungswiss. 15, 1-8.
9. Finkelstein J. D., (1998) The metabolism of homocysteine: pathways and regulation. Eur. J. Pediatr. 157, S40-44.
10. Fuso A., Nicolia V., Cavallaro R. A., Ricceri L., D'Anselmi F., Coluccia P., Calamandrei G., and, Scarpa S., (2008) B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell. Neurosci. 37, 731-746.
11. Ghribi O., Larsen B., Schrag M., and, Herman M. M., (2006) High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp. Neurol. 200, 460-467.
12. Ho P. I., Ashline D., Dhitavat S., Ortiz D., Collins S. C., Shea T. B., and, Rogers E., (2003) Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol. Dis. 14, 32-42.
13. Hofmann M. A., Lalla E., Lu Y., et al. (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107, 675-683.
14. Hossain M. A., Tsujita M., Akita N., Kobayashi F., and, Yokoyama S., (2009) Cholesterol homeostasis in ABCA1/LCAT double-deficient mouse. Biochim. Biophys. Acta 1791, 1197-1205.
15. Irizarry R. A., Hobbs B., Collin F., Beazer-Barclay Y. D., Antonellis K. J., Scherf U., and, Speed T. P., (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.
16. Jansen P. J., Lutjohann D., Thelen K. M., Von Bergmann K., Van Leuven F., Ramaekers F. C., and, Mulder M., (2009) Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels. J. Alzheimers Dis. 18, 319-329.
17. Koldamova R. P., Lefterov I. M., Staufenbiel M., Wolfe D., Huang S., Glorioso J. C., Walter M., Roth M. G., and, Lazo J. S., (2005) The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 280, 4079-4088.
18. Kruman I. I., Kumaravel T. S., Lohani A., Pedersen W. A., Cutler R. G., Kruman Y., Haughey N., Lee J., Evans M., and, Mattson M. P., (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J. Neurosci. 22, 1752-1762.
19. Lalonde R., Barraud H., Ravey J., Gueant J. L., Bronowicki J. P., and, Strazielle C., (2008) Effects of a B-vitamin-deficient diet on exploratory activity, motor coordination, and spatial learning in young adult Balb/c mice. Brain Res. 1188, 122-131.
20. Lewerin C., Matousek M., Steen G., Johansson B., Steen B., and, Nilsson-Ehle H., (2005) Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am. J. Clin. Nutr. 81, 1155-1162.
21. Liao D., Tan H., Hui R., et al. (2006) Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ. Res. 99, 598-606.
22. Luchsinger J. A., Tang M. X., Miller J., Green R., and, Mayeux R., (2007) Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch. Neurol. 64, 86-92.
23. Lund E. G., Xie C., Kotti T., Turley S. D., Dietschy J. M., and, Russell D. W., (2003) Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278, 22980-22988.
24. Luo Y., Zhou X., Yang X., and, Wang J., (2007) Homocysteine induces tau hyperphosphorylation in rats. Neuroreport 18, 2005-2008.
25. Lutjohann D., Harzer K., Gieselmann V., and, Eckhardt M., (2006) Reduced brain cholesterol content in arylsulfatase A-deficient mice. Biochem. Biophys. Res. Commun. 344, 647-650.
26. McCaddon A., Davies G., Hudson P., Tandy S., and, Cattell H., (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int. J. Geriatr. Psychiatry 13, 235-239.
27. McMahon J. A., Green T. J., Skeaff C. M., Knight R. G., Mann J. I., and, Williams S. M., (2006) A controlled trial of homocysteine lowering and cognitive performance. N. Engl. J. Med. 354, 2764-2772.
28. Morris M. C., Evans D. A., Schneider J. A., Tangney C. C., Bienias J. L., and, Aggarwal N. T., (2006) Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J. Alzheimers Dis. 9, 435-443.
29. Oulhaj A., Refsum H., Beaumont H., Williams J., King E., Jacoby R., and, Smith A. D., (2009) Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int. J. Geriatr. Psychiatry 25, 82-90.
30. Quan G., Xie C., Dietschy J. M., and, Turley S. D., (2003) Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res. Dev. Brain Res. 146, 87-98.
31. Sankaranarayanan S., Holahan M. A., Colussi D., et al. (2009) First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates. J. Pharmacol. Exp. Ther. 328, 131-140.
32. Selhub J., (1999) Homocysteine metabolism. Annu. Rev. Nutr. 19, 217-246.
33. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W., and, Wolf P. A., (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483. (Pubitemid 34441738)
34. Shea T. B., Ashline D., Ortiz D., Milhalik S., and, Rogers E., (2004) The S-adenosyl homocysteine hydrolase inhibitor 3-deaza-adenosine prevents oxidative damage and cognitive impairment following folate and vitamin E deprivation in a murine model of age-related, oxidative stress-induced neurodegeneration. Neuromolecular Med. 5, 171-180.
35. Shi X. P., Tugusheva K., Bruce J. E., et al. (2005) Novel mutations introduced at the beta-site of amyloid beta protein precursor enhance the production of amyloid beta peptide by BACE1 in vitro and in cells. J. Alzheimers Dis. 7, 139-148; discussion 173-180.
36. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C. G., and, Simons K., (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl Acad. Sci. USA 95, 6460-6464.
37. Sontag E., Nunbhakdi-Craig V., Sontag J. M., Diaz-Arrastia R., Ogris E., Dayal S., Lentz S. R., Arning E., and, Bottiglieri T., (2007) Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J. Neurosci. 27, 2751-2759.
38. Tchantchou F., Graves M., Ortiz D., Rogers E., and, Shea T. B., (2004) Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge: relevance to age-related neurodegeneration. Neuromolecular Med 6, 93-103.
39. Troen A. M., Lutgens E., Smith D. E., Rosenberg I. H., and, Selhub J., (2003) The atherogenic effect of excess methionine intake. Proc. Natl Acad. Sci. USA 100, 15089-15094.
40. Troen A. M., Shea-Budgell M., Shukitt-Hale B., Smith D. E., Selhub J., and, Rosenberg I. H., (2008a) B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc. Natl Acad. Sci. USA 105, 12474-12479.
41. Troen A. M., Chao W. H., Crivello N. A., D'Anci K. E., Shukitt-Hale B., Smith D. E., Selhub J., and, Rosenberg I. H., (2008b) Cognitive impairment in folate-deficient rats corresponds to depleted brain phosphatidylcholine and is prevented by dietary methionine without lowering plasma homocysteine. J. Nutr. 138, 2502-2509.
42. Van Dam F., and, Van Gool W. A., (2009) Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Arch Gerontol Geriatr 48, 425-430.
43. Varela-Moreiras G., and, Selhub J., (1992) Long-term folate deficiency alters folate content and distribution differentially in rat tissues. J. Nutr. 122, 986-991.
44. Velez-Carrasco W., Merkel M., Twiss C. O., and, Smith J. D., (2008) Dietary methionine effects on plasma homocysteine and HDL metabolism in mice. J. Nutr. Biochem. 19, 362-370.
45. Wahrle S. E., Jiang H., Parsadanian M., et al. (2008) Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118, 671-682.
46. Zhang C. E., Wei W., Liu Y. H., Peng J. H., Tian Q., Liu G. P., Zhang Y., and, Wang J. Z., (2009) Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 174, 1481-1491.
47. Zhou J., Moller J., Danielsen C. C., Bentzon J., Ravn H. B., Austin R. C., and, Falk E., (2001) Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21, 1470-1476.
48. Zhuo J. M., and, Pratico D., (2010) Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp. Gerontol. 45, 195-201.
49. Zhuo J. M., Portugal G. S., Kruger W. D., Wang H., Gould T. J., and, Pratico D., (2010) Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Curr. Alzheimer Res. 7, 140-149.